You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Patent: 10,383,876


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,383,876
Title:Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
Abstract: The present invention relates:--to 2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo-[1,2-- c]quinazolin-5-yl]pyrimidine-5-carboxamide dihydrochloride salt of formula (II): or a tautomer, solvate or hydrate thereof;--to methods of preparing said dihydrochloride salt;--to said dihydrochloride salt for the treatment and/or prophylaxis of a disease;--to the use of said dihydrochloride salt for the preparation of a medicament for the treatment and/or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, more particularly for the treatment or prophylaxis of a cancer, particularly lung cancer, in particular non-small cell lung carcinoma, colorectal cancer, melanoma, pancreatic cancer, hepatocyte carcinoma, pancreatic cancer, hepatocyte carcinoma or breast cancer;--to a pharmaceutical composition comprising said dihydrochloride salt; and--to a pharmaceutical combination comprising said dihydrochloride salt in combination with one or more further pharmaceutical agents. ##STR00001##
Inventor(s): Peters; Jan-Georg (Solingen, DE), Militzer; Hans-Christian (Odenthal, DE), Muller; Hartwig (Velbert, DE)
Assignee: BAYER INTELLECTUAL PROPERTY GMBH (Monheim, DE)
Application Number:14/009,599
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 10,383,876

Introduction

Understanding the intricacies of a patent, particularly one like United States Patent 10,383,876, involves a detailed analysis of its claims, the broader patent landscape, and the legal and technological contexts in which it operates. This article will delve into these aspects to provide a comprehensive and critical analysis.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and the rights granted to the patent holder. For U.S. Patent 10,383,876, it is crucial to analyze each claim to determine what is protected and what is not.

Claim Structure

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are critical in determining the scope of the patent.
  • Dependent Claims: These claims refer back to and further limit the independent claims, often adding specific details or narrowing the scope[5].

Claim Analysis

To analyze the claims of U.S. Patent 10,383,876, one must carefully read each claim, identifying key elements, limitations, and any dependencies. This involves understanding the technical language and the specific features of the invention that are being claimed.

Patent Allowance Rates and Trends

The probability of a patent being granted is an important factor in understanding the patent landscape. Research indicates that only about 55.8% of patent applications filed at the U.S. Patent and Trademark Office (USPTO) between 1996 and 2005 were eventually granted without using continuation procedures[1].

Declining Allowance Rates

  • The allowance rate for patent applications has decreased over time, particularly in fields like "Drugs and Medical Instruments" and "Computers and Communications"[1].
  • This decline suggests a more stringent examination process, which can impact the validity and strength of patents in these fields.

Patent Family and Continuation Applications

Understanding the patent family and continuation applications is vital for a comprehensive analysis.

Patent Family Analysis

  • A patent family includes the original application (progenitor) and any subsequent applications derived from it through continuation procedures[1].
  • Analyzing the patent family helps in determining the geographical coverage and the evolution of the invention over time[5].

Continuation Applications

  • Continuation applications allow applicants to pursue additional patents based on the same invention, but they must disclaim any term that would extend the patent term of an already-issued patent[2].
  • This process can complicate the patent landscape, as claims may be amended or narrowed during prosecution, leading to variations within the patent family[3].

Prior Art and Novelty

Prior art searches are essential to determine the novelty and non-obviousness of an invention.

Prior Art Searching

  • Effective prior art searches involve examining existing technologies or innovations that may affect the validity or patentability of the new invention[5].
  • Advanced search tools, including AI algorithms, can improve the efficiency and comprehensiveness of these searches[3].

Legal and Regulatory Compliance

Understanding the legal framework surrounding patents is crucial.

Obviousness-Type Double Patenting (ODP)

  • ODP prevents a subsequent patent from being granted on the same invention as an earlier granted patent or an obvious modification thereof[2].
  • The Federal Circuit has emphasized the importance of terminal disclaimers to avoid ODP issues, particularly when Patent Term Adjustments (PTA) are involved[2].

Competitive Landscape and Market Dynamics

Analyzing the competitive landscape helps in understanding the market dynamics and the position of the patent within it.

Patent Valuation

  • The value of a patent can be significant, with median prices ranging from $108,000 to $250,000 per family, depending on the technology and market[4].
  • Companies often use patent analysis to assess their intellectual property portfolios and make informed decisions about licensing, mergers, and acquisitions[5].

R&D Strategy

  • By analyzing patents in a particular field, organizations can refine their R&D strategies, identifying white spaces or areas with fewer patents, which indicate potential opportunities for innovation[5].

Technology Classification and Trends

Classifying patents by technology area helps in analyzing and comparing them.

Technology Classification

  • Assigning appropriate technology classifications or codes to patents categorizes them by technology area, making it easier to analyze and compare[5].
  • Trends in patent filings over time can reveal the evolution of technology in the field, identifying peaks and valleys in innovation activity[5].

Citation Analysis and Keyword Analysis

Citation and keyword analyses provide insights into the importance and relevance of a patent.

Citation Analysis

  • Examining patent citations helps understand how a patent relates to prior and subsequent innovations, gauging its importance within a technological field[5].

Keyword Analysis

  • Using natural language processing (NLP) and text mining techniques to analyze patent titles and abstracts for common keywords and trends can reveal patterns and hotspots in innovation[5].

Visualizations and Presentation

Presenting findings visually can make complex data more compelling.

Visualizations

  • Creating visualizations like heat maps, network graphs, and trend charts helps present findings in a visually compelling manner, facilitating better understanding and decision-making[5].

Key Takeaways

  • Claim Analysis: Carefully analyze each claim to understand the scope and limitations of the patent.
  • Patent Allowance Rates: Be aware of the declining allowance rates and their implications on patent strength.
  • Patent Family: Understand the patent family and continuation applications to grasp the full scope of the invention.
  • Prior Art: Conduct thorough prior art searches to ensure novelty and non-obviousness.
  • Legal Compliance: Ensure compliance with legal frameworks, particularly regarding ODP and PTA.
  • Competitive Landscape: Analyze the competitive landscape to understand market dynamics and the patent's value.
  • Technology Trends: Classify patents by technology area and analyze trends to identify innovation opportunities.

FAQs

Q: What is the average allowance rate for patent applications at the USPTO?

A: The average allowance rate for patent applications at the USPTO is approximately 55.8% without using continuation procedures[1].

Q: How do continuation applications affect the patent landscape?

A: Continuation applications can lead to variations in claims within the patent family and require terminal disclaimers to avoid ODP issues[2].

Q: What is the importance of prior art searches in the patent application process?

A: Prior art searches are crucial to determine the novelty and non-obviousness of an invention, ensuring the patent's validity[5].

Q: How can AI tools enhance patent searches?

A: AI tools can improve the efficiency and comprehensiveness of patent searches by pulling in relevant results that may have been missed[3].

Q: What is the median value of a patent family?

A: The median value of a patent family can range from $108,000 to $250,000, depending on the technology and market[4].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Mintz. (2023, September 7). Federal Circuit Puts the Onus on Patent Owners to Disclaim Patent. Mintz.
  3. CAS. (2023, July 24). Advanced patent searching techniques. CAS.org.
  4. Perpetual Motion Patents. The value of a patent. Perpetual Motion Patents Ltd.
  5. Evalueserve. Patent Analysis. Evalueserve.

More… ↓

⤷  Subscribe

Details for Patent 10,383,876

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 January 10, 1978 ⤷  Subscribe 2031-04-05
Amgen Inc. EPOGEN/PROCRIT epoetin alfa Injection 103234 June 01, 1989 ⤷  Subscribe 2031-04-05
Amgen Inc. EPOGEN/PROCRIT epoetin alfa Injection 103234 ⤷  Subscribe 2031-04-05
Amgen Inc. PROCRIT epoetin alfa Injection 103234 ⤷  Subscribe 2031-04-05
Iovance Biotherapeutics Manufacturing Llc PROLEUKIN aldesleukin For Injection 103293 May 05, 1992 ⤷  Subscribe 2031-04-05
Amgen Inc. NEUPOGEN filgrastim Injection 103353 February 20, 1991 ⤷  Subscribe 2031-04-05
Amgen Inc. NEUPOGEN filgrastim Injection 103353 June 28, 2000 ⤷  Subscribe 2031-04-05
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.